Sage Partners’s Zai Lab ZLAB Stock Holding History

Sage Partners’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-28,952	Closed	-$1.82M	–	3
2021 Q4	$1.82M	Buy	+28,952	New	+$2.45M	14.04%	2

Other funds holding ZLAB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sage Partners's ZLAB Position: Q1 2022 in Review

Sage Partners sold out of Zai Lab (ZLAB) in Q1 2022, closing a stake of 28,952 shares — an estimated $1.82M sold.

Sage Partners first reported a position in ZLAB in Q4 2021 and held it in 1 quarter. The position peaked at $1.82M in Q4 2021. 176 funds tracked by Wall St. Rank hold ZLAB as of Q1 2022.

Sage Partners reported no remaining Zai Lab position as of Q1 2022 after selling out during the quarter.
Sage Partners sold 28,952 Zai Lab shares in Q1 2022, an estimated $1.82M.
Sage Partners first reported a position in Zai Lab in Q4 2021 and held it in 1 quarter.
Sage Partners's Zai Lab position peaked at $1.82M in Q4 2021.
176 funds tracked by Wall St. Rank held Zai Lab as of Q1 2022.

Based on Sage Partners's 13F filing for Q1 2022, filed 4 May 2022.